(Q36809886)

16 August 2017

1 reference

title

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance (English)

1 reference

inflammatory bowel diseases

16 August 2017

main subject

0 references

1 reference

2

Markus F Neurath

1 reference

16 August 2017

Jonas Mudter

1

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Inflammatory Bowel Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

13

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

1016-1023

1 reference

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

16 August 2017

cites work

1 reference

The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases

21 January 2018

1 reference

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

21 January 2018

1 reference

IL6 and the acute phase reaction

21 January 2018

1 reference

Inflammatory Bowel Disease

21 January 2018

1 reference

21 January 2018

1 reference

The mucosal immune system

21 January 2018

1 reference

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

IL-6 trans-signaling: the heat is on.

21 January 2018

1 reference

IL-6 transsignaling: the in vivo consequences

21 January 2018

1 reference

Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease

21 January 2018

1 reference

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

21 January 2018

1 reference

21 January 2018

IL-6 and Crohns Disease

1 reference

Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.

21 January 2018

1 reference

Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question

21 January 2018

1 reference

C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

21 January 2018

1 reference

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children

21 January 2018

1 reference

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

21 January 2018

1 reference

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

21 January 2018

1 reference

Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

21 January 2018

1 reference

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis

21 January 2018

1 reference

IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

21 January 2018

1 reference

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

21 January 2018

1 reference

Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation.

21 January 2018

1 reference

Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence

21 January 2018

1 reference

Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study

21 January 2018

1 reference

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease

21 January 2018

1 reference

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20148

1 reference

16 August 2017

1 reference